Autologous Platelet Rich Plasma on Low Back Pain
Unknown statusNot applicableNCT02983747
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the effectiveness of autologous platelet-rich plasma (PRP) injection therapy for low back pain patients. Our hypothesis is that PRP will reduce the pain feeling and benefit for restore of the intervertebral disk.
Study details
- Official title
- Autologous Platelet Rich Plasma in Ultrasound Guided Intervertebral Disk Injection Therapy for Chronic Low Back Pain
- Conditions
- Interventions
- Other: PRP Treatment(P)
- Drug: Medication Treatment(Loxoprofen Sodium tablets,M)
- Sponsor
- Shanghai Changzheng Hospital
- Start date
- 2019-11-01
- Primary completion
- 2022-12-30
- Sex
- Male
- Age range
- from 18 Years to 45 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic low back pain more than 2months * Visual analog scale score more than 4 * Positive X-ray, MRI or CT scan findings * Pfirrmann grading I-III * Well understanding and communication ability Exclusion Criteria: * History of allergy * Hemorrhagic trend or use of anticoagulant therapy * Mental diseases * Active infection or recent infectious diseases within 3 months * Local skin infection near the puncture location * Severe lumbar spinal stenosis, lumbar spondylolisthesis, ossification of posterior longitudinal * Ligament and lumbar disc herniation（more than 5mm） * Immunologic diseases * Tumors * Metastatic disease * Recent surgery less than 3 months) * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02983747